Financial Affordability and SustainabilityCancer care may create financial hardship for patients.It is critical for the cancer care team to assess needs throughout the care journey, connecting patients and their caregivers with team members who can help to navigate financial barriers and identify available financial assistance programs.Novel innovative therapies are often not fully covered by insurance providers and in some cases, may not be covered at all.Provider organizations should establish a process to verify benefits and secure any necessary prior authorizations.This ensures potential barriers or coverage gaps for BsAbs and supportive care medications are identified early and addressed promptly, minimizing any treatment delays. Patient and Caregiver Education and EngagementPatients and caregivers must be informed about the potential adverse events related to BsAb treatment.Education should review strategies for preventing toxicities and how symptoms will be managed if they occur.Useful resources include patient wallet cards, emergency contact numbers, and a list of symptoms to monitor.Equally important is ensuring that cancer care team members stay up to date on the latest recommendations and guidelines for preventing and managing toxicities that may result from BsAb treatment. Key principles include promoting

With the ongoing workforce challenges plaguing the health care industry, health systems are developing new and innovative strategies to bolster their pipeline of health care employees to meet growing patient needs.In oncology, the challenge of attracting, recruiting, and retaining qualified team members is especially acute.Through strategic partnerships with groups across the health care landscape, Inova Schar Cancer (Inova Schar) in Fairfax, Virginia, has successfully addressed some of these acute needs within the areas of clinical research, phlebotomy, medical physics, and dosimetry. Clinical ResearchIn 2021, Inova Schar's clinical research team was experiencing higherthan-expected turnover rates.As is common with people filling various clinical research roles, team members were leaving for good reasons including enrollment in medical school, nursing school, and other graduate or educational programs.However, this turnover was exacerbated by the COVID-19 pandemic, resulting in new challenges to retain and attract team members.By the end of 2020, the clinical research team was facing a risk of insufficient staffing for the Inova Schar's growing research volumes.To address the anticipated need, senior director Stephanie Van Bebber, MSc, CCRP, senior director of the clinical trials office at Inova Schar, and her leaders began to brainstorm ideas to foster interest in clinical research both internally and externally.Key initiatives included building a robust education and training program for both non-research and research personnel, professionalizing the research positions, and creating a program to develop a future pipeline for clinical research professionals.

Cincinnati, Ohiofrom physical symptoms to social, emotional, and spiritual support.By collaborating with community resources, OHC helps patients to navigate the challenges of cancer treatment and maintain their dignity and well-being.